论文部分内容阅读
为进一步阐明系统性红斑狼疮(SLE)和细胞性免疫的关系,作者选择了细胞免疫的体外试验一周围淋巴细胞转化(母细胞化)试验及巨噬细胞移动抑制试验对SLE患者进行研究,其结果如下: 一、周围淋巴细胞转化试验: 1.添加植物血凝素—促分裂素(PHA-M)的转化率:采取周围淋巴细胞,加入PHA-M0.5毫克/毫升培养,测定其转化率,12名正常人的范围为45.5～70.1％,平均值为57.3％;22名SLE患者的范围为14.8～84.0％,平均值为50.6％,二组平均值比较,虽无明显差别,但在SLE患者组中各个
To further elucidate the relationship between systemic lupus erythematosus (SLE) and cellular immunity, the authors selected the in vitro immunocytochemistry-peripheral lymphocyte transformation (blastocyst) assay and the macrophage migration inhibitory assay to study patients with SLE The results are as follows: First, the surrounding lymphocyte transformation test: 1. The addition of phytohemagglutinin (PHA-M) conversion rate: take peripheral lymphocytes, added PHA-M0.5 mg / ml culture, measured the conversion Rate, 12 normal ranged from 45.5% to 70.1% with an average of 57.3%. The range of 22 SLE patients ranged from 14.8% to 84.0% with an average of 50.6%. There was no significant difference between the two groups In the SLE patient group each